Detalhe da pesquisa
1.
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
Inflammopharmacology
; 32(1): 433-446, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477795
2.
Synthesis and cytotoxic activity of new acridine-thiazolidine derivatives.
Bioorg Med Chem
; 20(11): 3533-9, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22546208
3.
Imidazolidine Derivatives in Cancer Research: What is known?
Anticancer Agents Med Chem
; 22(7): 1272-1277, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34315391
4.
New Trends in Biological Activities and Clinical Studies of Quinolinic Analogues: A Review.
Curr Drug Targets
; 23(5): 441-457, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858312
5.
Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?
Curr Drug Targets
; 20(6): 635-654, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30474528
6.
Synthesis and in vitro anticancer activity of new 2-thioxo-oxazolidin-4-one derivatives.
Pharmacol Rep
; 69(4): 633-641, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28511054
7.
The evolution of drugs on schistosoma treatment: looking to the past to improve the future.
Mini Rev Med Chem
; 13(4): 493-508, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23373654
8.
Development of novel therapeutic drugs in humans from plant antimicrobial peptides.
Curr Protein Pept Sci
; 11(3): 236-47, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20088768